TrialBone marrow transplantation2014

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease.

M Bhatia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.